Synopsis:
Chemotherapy is an important part of combined therapy for non-small cell lung cancer and can enhance the survival rate of patients subjected to surgery. This study aimed to compare the efficacy and toxicity of docetaxel combined with cisplatin (DP) and gemcitabine combined with cisplatin (GP) in postoperative chemotherapy after surgery of non-small cell lung cancer NSCLC.